Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis

D Adeloye, P Song, Y Zhu, H Campbell… - The Lancet …, 2022 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) is an increasingly important
cause of morbidity, disability, and mortality worldwide. We aimed to estimate global …

Decellularized extracellular matrix: New promising and challenging biomaterials for regenerative medicine

M Brown, J Li, C Moraes, M Tabrizian, NYK Li-Jessen - Biomaterials, 2022 - Elsevier
Extracellular matrix is rich in biomolecules including structural proteins,
glycosaminoglycans, and small molecules that are important for the maintenance and repair …

Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease …

S Safiri, K Carson-Chahhoud, M Noori… - Bmj, 2022 - bmj.com
Objective To report the global, regional, and national burden of chronic obstructive
pulmonary disease (COPD) and its attributable risk factors between 1990 and 2019, by age …

Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease

KL Bowerman, SF Rehman, A Vaughan… - Nature …, 2020 - nature.com
Chronic obstructive pulmonary disease (COPD) is the third commonest cause of death
globally, and manifests as a progressive inflammatory lung disease with no curative …

Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study

C Wang, J Xu, L Yang, Y Xu, X Zhang, C Bai, J Kang… - The Lancet, 2018 - thelancet.com
Background Although exposure to cigarette smoking and air pollution is common, the
current prevalence of chronic obstructive pulmonary disease (COPD) is unknown in the …

[HTML][HTML] Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and …

GBD 2015 Chronic Respiratory Disease … - The Lancet …, 2017 - ncbi.nlm.nih.gov
Background Chronic obstructive pulmonary disease (COPD) and asthma are common
diseases with a heterogeneous distribution worldwide. Here, we present methods and …

[HTML][HTML] Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and …

JB Soriano, AA Abajobir, KH Abate… - The Lancet …, 2017 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) and asthma are common
diseases with a heterogeneous distribution worldwide. Here, we present methods and …

Inference of chronic obstructive pulmonary disease with deep learning on raw spirograms identifies new genetic loci and improves risk models

J Cosentino, B Behsaz, B Alipanahi, ZR McCaw… - Nature Genetics, 2023 - nature.com
Chronic obstructive pulmonary disease (COPD), the third leading cause of death worldwide,
is highly heritable. While COPD is clinically defined by applying thresholds to summary …

Global burden of chronic obstructive pulmonary disease through 2050

E Boers, M Barrett, JG Su, AV Benjafield… - JAMA Network …, 2023 - jamanetwork.com
Importance Chronic obstructive pulmonary disease (COPD) is a respiratory condition that is
associated with significant health and economic burden worldwide. Previous studies …

[HTML][HTML] Global and regional estimates of COPD prevalence: Systematic review and meta–analysis

D Adeloye, S Chua, C Lee, C Basquill… - Journal of global …, 2015 - ncbi.nlm.nih.gov
Background The burden of chronic obstructive pulmonary disease (COPD) across many
world regions is high. We aim to estimate COPD prevalence and number of disease cases …